Correlation Between First Wave and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both First Wave and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining First Wave and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between First Wave BioPharma and Akari Therapeutics PLC, you can compare the effects of market volatilities on First Wave and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in First Wave with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of First Wave and Akari Therapeutics.
Diversification Opportunities for First Wave and Akari Therapeutics
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between First and Akari is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding First Wave BioPharma and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and First Wave is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on First Wave BioPharma are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of First Wave i.e., First Wave and Akari Therapeutics go up and down completely randomly.
Pair Corralation between First Wave and Akari Therapeutics
If you would invest 61.00 in First Wave BioPharma on August 25, 2024 and sell it today you would earn a total of 0.00 from holding First Wave BioPharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 4.55% |
| Values | Daily Returns |
First Wave BioPharma vs. Akari Therapeutics PLC
Performance |
| Timeline |
| First Wave BioPharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Akari Therapeutics PLC |
First Wave and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with First Wave and Akari Therapeutics
The main advantage of trading using opposite First Wave and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if First Wave position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| First Wave vs. Quoin Pharmaceuticals Ltd | First Wave vs. Revelation Biosciences | First Wave vs. Dermata Therapeutics | First Wave vs. LMF Acquisition Opportunities |
| Akari Therapeutics vs. Lyra Therapeutics | Akari Therapeutics vs. Hookipa Pharma | Akari Therapeutics vs. SAB Biotherapeutics | Akari Therapeutics vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |